Berapa banyak dividen yang dibayarkan Ono Pharmaceutical Co 2025?
Berdasarkan data terkini dari Juli 2025, Ono Pharmaceutical Co telah membayar dividen sejumlah total 40,00 JPY per saham dalam 12 bulan terakhir. Dengan kurs Ono Pharmaceutical Co saat ini sebesar 1.549,50 JPY, ini setara dengan yield dividen sebesar 2,58 %.
Dividen dibayarkan sebanyak 2 kali per tahun.
2,58 % Dividen Yield | = | 40,00 JPY Dividen | 1.549,50 JPY Harga Saham |
|
Apakah dividen Ono Pharmaceutical Co aman?
Ono Pharmaceutical Co meningkatkan dividen sejak 3 tahun.
Dalam kurun waktu 10 tahun terakhir, Ono Pharmaceutical Co telah meningkatkan sebesar 1,059 % setiap tahunnya.
Dalam kurun waktu 5 tahun, turun pembagian dividen meningkat sebesar -2,328 %.
Analis memperkirakan untuk tahun fiskal yang sedang berjalan akan terjadi pertumbuhan sebesar Kenaikan Dividen%.
Ono Pharmaceutical Co Aktienanalyse
Apa yang dilakukan Ono Pharmaceutical Co?
Ono Pharmaceutical Co Ltd is a Japanese company specialized in the development and marketing of innovative medications. It has a long history, being founded in 1717. Originally, it was a Chinese medicine business, but since its establishment in 1924, Ono Pharmaceutical has focused on the development of modern medications.
The company's business model is based on research and development of medications. Ono Pharmaceutical has several branches in different countries and works closely with research institutions and universities to develop groundbreaking medications. The company is committed to providing innovative therapies to patients worldwide.
Ono Pharmaceutical specializes in several areas, including oncology, immunology, neurology, and diabetes. In oncology, the company has launched several medications, including Opdivo and Sprycel, used for the treatment of various forms of cancer. Opdivo is an immunooncological medication that shows great promise and is used worldwide.
In immunology, Ono Pharmaceutical has developed a range of medications, including Nivolumab, used for the treatment of various autoimmune diseases such as rheumatoid arthritis. Ono Pharmaceutical has also developed medications for influenza and other types of infections.
In the field of neurology, the company has developed medications used for pain treatment, including the compound Fauldopamine. Despite the discovery of Fauldopamine, which is considered suitable for pain treatment, no final decision has been made regarding the application of this medication.
In diabetes research, Ono Pharmaceutical has developed various medications used for the treatment of diabetes, including Alogliptin and Canagliflozin. These medications help diabetics better control their blood sugar levels and alleviate the symptoms of this disease.
Ono Pharmaceutical has also launched numerous products used in different areas, such as Desitin, a cream for the treatment of skin disorders, or Minon, a skincare line.
The company places great importance on collaboration and innovation to provide highly effective medications to patients. Ono Pharmaceutical is committed to expanding its presence in the global market and developing further innovative therapies to improve people's lives. Ono Pharmaceutical Co adalah salah satu perusahaan paling populer di Eulerpool.com.Rencana tabungan saham menawarkan kesempatan menarik bagi investor untuk membangun kekayaan jangka panjang. Salah satu keuntungan utamanya adalah efek rata-rata biaya: Dengan berinvestasi dalam jumlah tetap secara reguler ke dalam saham atau dana saham, otomatis anda akan membeli lebih banyak saham ketika harga rendah, dan lebih sedikit ketika harga tinggi. Hal ini dapat menghasilkan harga rata-rata per saham yang lebih menguntungkan seiring waktu. Selain itu, rencana tabungan saham juga memungkinkan investor kecil untuk mengakses saham-saham mahal, karena mereka dapat berpartisipasi dengan jumlah yang kecil. Investasi rutin juga mendukung strategi investasi yang disiplin dan membantu menghindari keputusan emosional, seperti membeli atau menjual secara impulsif. Di samping itu, investor juga mendapat manfaat dari potensi peningkatan nilai saham serta dari pembagian dividen, yang bisa direinvestasikan, meningkatkan efek bunga majemuk dan dengan demikian pertumbuhan dari modal yang diinvestasikan.